AssetMark Inc’s BioSpecifics Technologies Corp. BSTC Stock Holding History

AssetMark Inc’s Portfolio BSTC Stock Details BSTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-25	Closed	-$1K	–	1525
2020 Q3	$1K	Hold	25	–	–	﹤0.01%	1301
2020 Q2	$2K	Buy	25 +8	+47%	+$463	﹤0.01%	1146
2020 Q1	$1K	Sell	17 -47	-73%	-$2.68K	﹤0.01%	1330
2019 Q4	$4K	Buy	64 +41	+178%	+$2.17K	﹤0.01%	1156
2019 Q3	$1K	Buy	23 +7	+44%	+$407	﹤0.01%	1296
2019 Q2	$1K	Buy	16 +6	+60%	+$378	﹤0.01%	1319
2019 Q1	$1K	Buy	+10	New	+$661	﹤0.01%	1318
2017 Q2	–	Sell	-3	Closed	–	–	1522
2017 Q1	$0	Buy	+3	New	+$159	﹤0.01%	1503

Other funds holding BSTC

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

AssetMark Inc's BSTC Position: Q4 2020 in Review

AssetMark Inc sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2020, closing a stake of 25 shares — an estimated $1K sold.

AssetMark Inc first reported a position in BSTC in Q1 2017 and held it in 8 quarters. The position peaked at $4K in Q4 2019. 1 fund tracked by Wall St. Rank holds BSTC as of Q4 2020.

AssetMark Inc reported no remaining BioSpecifics Technologies Corp. position as of Q4 2020 after selling out during the quarter.
AssetMark Inc sold 25 BioSpecifics Technologies Corp. shares in Q4 2020, an estimated $1K.
AssetMark Inc first reported a position in BioSpecifics Technologies Corp. in Q1 2017 and held it in 8 quarters.
AssetMark Inc's BioSpecifics Technologies Corp. position peaked at $4K in Q4 2019.
1 fund tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2020.

Based on AssetMark Inc's 13F filing for Q4 2020, filed 10 Feb 2021.